Nan Xie

1.4k total citations
64 papers, 1.1k citations indexed

About

Nan Xie is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Nan Xie has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Oncology and 14 papers in Surgery. Recurrent topics in Nan Xie's work include Cancer-related molecular mechanisms research (7 papers), Head and Neck Cancer Studies (6 papers) and Cancer Cells and Metastasis (5 papers). Nan Xie is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Head and Neck Cancer Studies (6 papers) and Cancer Cells and Metastasis (5 papers). Nan Xie collaborates with scholars based in China, United States and Australia. Nan Xie's co-authors include Cheng Wang, Xiqiang Liu, Jinsong Hou, Hongzhang Huang, Bin Chen, Li‐Zhu Wu, Ke Feng, Chen‐Ho Tung, Haichao Liu and Yue Zhu and has published in prestigious journals such as Macromolecules, Chemical Communications and Scientific Reports.

In The Last Decade

Nan Xie

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nan Xie China 19 431 314 249 192 158 64 1.1k
Dongwang Zhu China 23 805 1.9× 371 1.2× 511 2.1× 125 0.7× 92 0.6× 56 1.5k
Yuhua Hu China 14 384 0.9× 221 0.7× 88 0.4× 193 1.0× 41 0.3× 36 997
Shuwei Chen China 20 426 1.0× 202 0.6× 216 0.9× 102 0.5× 23 0.1× 51 871
Yun Zhu China 23 522 1.2× 253 0.8× 244 1.0× 171 0.9× 116 0.7× 63 1.3k
Anxun Wang China 21 799 1.9× 247 0.8× 352 1.4× 131 0.7× 33 0.2× 34 1.2k
Donghai Huang China 24 815 1.9× 380 1.2× 377 1.5× 118 0.6× 28 0.2× 60 1.3k
Shuyang Sun China 25 884 2.1× 502 1.6× 354 1.4× 93 0.5× 111 0.7× 46 1.6k
Akio Mizuno Japan 21 481 1.1× 307 1.0× 121 0.5× 172 0.9× 37 0.2× 80 1.2k
Shufang Jin China 19 507 1.2× 189 0.6× 342 1.4× 120 0.6× 45 0.3× 38 870
Tianrui Chen China 14 462 1.1× 272 0.9× 380 1.5× 107 0.6× 95 0.6× 25 1.1k

Countries citing papers authored by Nan Xie

Since Specialization
Citations

This map shows the geographic impact of Nan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Xie more than expected).

Fields of papers citing papers by Nan Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Xie. The network helps show where Nan Xie may publish in the future.

Co-authorship network of co-authors of Nan Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Xie. A scholar is included among the top collaborators of Nan Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Xie. Nan Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Nan, Hao Zhang, Li Zhong, et al.. (2025). Somatization symptoms and burnout: a correlational study among emergency nurses. Frontiers in Public Health. 13. 1647123–1647123.
2.
He, Sijie, Zhao‐Yang Wang, Xue‐Wang Gao, et al.. (2024). Photofabrication of fluorescent nanospheres from de novo designed peptides, and their enzyme-responsive dissociation in living cells. Materials Advances. 5(7). 2888–2897. 2 indexed citations
3.
Xiong, Gan, Nan Xie, Rongsong Ling, et al.. (2024). Single-cell transcriptomics reveals cell atlas and identifies cycling tumor cells responsible for recurrence in ameloblastoma. International Journal of Oral Science. 16(1). 21–21. 6 indexed citations
4.
Xie, Nan, et al.. (2024). So many measures in ERAS protocol: Which matters most?. Nutrition. 122. 112384–112384. 1 indexed citations
5.
Liu, Hao, Sijie He, Li‐Ya Niu, et al.. (2023). Peptide photowrapping of gold-silica nanocomposites for constructing MMP-responsive drug capsules for chemo-photothermal therapy. Chemical Communications. 59(34). 5059–5062. 3 indexed citations
6.
Aktar, Sharmin, Farhadul Islam, Sujani Madhurika Kodagoda Gamage, et al.. (2023). Correlation between KRAS Mutation and CTLA-4 mRNA Expression in Circulating Tumour Cells: Clinical Implications in Colorectal Cancer. Genes. 14(9). 1808–1808. 2 indexed citations
7.
Jiang, Yu, Xiaoqian Tan, Wentao Ma, et al.. (2023). The suppression of hyperlipid diet‐induced ferroptosis of vascular smooth muscle cells protests against atherosclerosis independent of p53/SCL7A11/GPX4 axis. Journal of Cellular Physiology. 238(8). 1891–1908. 18 indexed citations
8.
Tan, Xiaoqian, Yu Jiang, Pin Li, et al.. (2023). P53: A Key Target in the Development of Osteoarthritis. Molecular Biotechnology. 66(1). 1–10. 10 indexed citations
9.
Feng, Juan, Jiamin Xu, Haiyan Fu, et al.. (2023). Prognostic scores in primary biliary cholangitis patients with advanced disease. World Journal of Gastrointestinal Surgery. 15(8). 1774–1783. 4 indexed citations
10.
Wang, Wenjin, Zhikun Ma, Gan Xiong, et al.. (2023). CYTOR Facilitates Formation of FOSL1 Phase Separation and Super Enhancers to Drive Metastasis of Tumor Budding Cells in Head and Neck Squamous Cell Carcinoma. Advanced Science. 11(4). e2305002–e2305002. 13 indexed citations
11.
Chen, Qijun, Lixue Wang, Hui Song, et al.. (2023). Deficiency of SR‐B1 reduced the tumor load of colitis‐induced or APCmin/+‐induced colorectal cancer. Cancer Medicine. 12(19). 19744–19757. 7 indexed citations
12.
Wang, Wenjin, Nan Xie, Yi Chen, et al.. (2022). Prognostic and clinicopathological significance of cytocapsular tubes in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 51(6). 520–528. 2 indexed citations
13.
Xie, Nan, et al.. (2022). Baseline assessment of enhanced recovery after pediatric surgery in mainland China. Pediatric Surgery International. 39(1). 32–32. 4 indexed citations
14.
Fan, Song, Hongshi Cai, Yan Liao, et al.. (2021). The systemic inflammation response index predicts the survival of patients with clinical T1‐2N0 oral squamous cell carcinoma. Oral Diseases. 28(3). 600–610. 4 indexed citations
15.
Wang, Cheng, et al.. (2021). Prognostic value of tertiary lymphoid structures in early clinical stage oral tongue squamous cell carcinoma. Journal of Oral Pathology and Medicine. 50(8). 776–784. 11 indexed citations
16.
Zhang, Ming, Zhikun Ma, Bo Sun, et al.. (2021). FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program. Molecular Therapy. 29(8). 2583–2600. 71 indexed citations
17.
Xie, Nan, Jiabin Cai, Lu Zhang, et al.. (2017). Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma. Cell Death and Disease. 8(12). 3205–3205. 38 indexed citations
18.
Xie, Nan, et al.. (2016). Proteomic analysis of the effects of CSF-1 and IL-1α on dental follicle cells. Molecular Medicine Reports. 14(3). 2405–2414. 5 indexed citations
19.
Feng, Ke, Nan Xie, Bin Chen, Chen‐Ho Tung, & Li‐Zhu Wu. (2016). Modular Design of Poly(norbornenes) for Organelle-Specific Imaging in Tumor Cells. Biomacromolecules. 17(2). 538–545. 14 indexed citations
20.
Hu, Fengchun, Xiaohua Chen, Xiqiang Liu, et al.. (2015). Clinicopathological features and prognostic implications of Raf kinase inhibitor protein downregulation in tongue squamous cell carcinoma. Oncology Letters. 10(3). 1303–1308. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026